PEPCK Monoclonal Antibody

This gene encodes a mitochondrial enzyme that catalyzes the conversion of oxaloacetate to phosphoenolpyruvate in the presence of guanosine triphosphate (GTP). A cytosolic form of this protein is encoded by a different gene and is the key enzyme of gluconeogenesis in the liver. Alternatively spliced transcript variants have been described.

Introducing the PEPCK Monoclonal Antibody, a cutting-edge scientific tool designed to revolutionize research in the field of biochemistry. This highly specific antibody is meticulously engineered to target and bind to the phosphoenolpyruvate carboxykinase (PEPCK) enzyme, enabling researchers to gain invaluable insights into its function and regulation.

Crafted with utmost precision, the PEPCK Monoclonal Antibody boasts exceptional affinity and selectivity, ensuring accurate and reliable results. Its monoclonal nature guarantees consistency and reproducibility, making it an indispensable asset for any laboratory seeking to advance their understanding of PEPCK-related processes.

With its versatile applications, this antibody opens up a myriad of possibilities for scientific exploration. Whether investigating metabolic pathways, studying gluconeogenesis, or elucidating the role of PEPCK in various diseases, the PEPCK Monoclonal Antibody provides an indispensable tool for researchers aiming to unravel the complexities of this crucial enzyme.

Furthermore, the PEPCK Monoclonal Antibody is manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to ensure optimal performance, guaranteeing the utmost reliability and accuracy in experimental outcomes.

In summary, the PEPCK Monoclonal Antibody represents a breakthrough in biochemistry research, offering unparalleled specificity, reliability, and versatility. With its exceptional affinity and meticulous manufacturing process, this antibody is poised to empower scientists in their quest for scientific discovery and innovation.